Administrative and Engagement Core

行政和参与核心

• 批准号: 10738440
• 负责人: Juliet Iwelunmor
• 金额: $ 19.84万
• 依托单位: WASHINGTON UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2023
• 资助国家: 美国
• 起止时间: 2023-09-19 至 2028-08-31
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10738440
• 关键词: Acceleration; Address; Adoption; Attention; Award; Cancer Control; Cancer Vaccines; Caring; Cervical cancer vaccine; Cessation of life; Clinical Services; Collaborations; Communication; Communities; Community Outreach; Country; Creativeness; Development; Educational workshop; Ensure; Environment; Equity; Ethics; Evaluation; Fostering; Foundations; Goals; Guidelines; Health; Health system; Hepatitis B Vaccines; Human Papilloma Virus Vaccine; Human Resources; Incidence; Individual; Infrastructure; Intervention; Logistics; Malignant Neoplasms; Malignant neoplasm of cervix uteri; Malignant neoplasm of liver; Medical Research; Methods; Modeling; Nigeria; Nigerian; North Carolina; Persons; Prevention; Process; Protocols documentation; Public Health; Research; Research Institute; Research Personnel; Resource-limited setting; Role; Societies; Surveys; Teleconferences; Testing; Training; Translational Research; Travel; United States National Institutes of Health; Universities; Vaccines; Visual impairment; World Health Organization; access disparities; community engagement; community involvement; community setting; cost; crowdsourcing; evidence base; health goals; implementation science; implementation strategy; improved; mortality; novel; operation; outreach; programs; response; success; symposium

Nigeria is at a crossroads in its cancer control response. On the one hand, the country remains an epicenter of a growing cancer crisis. On the other hand, there are existing guidelines (e.g., the National Cancer Control Plan2 by the Nigerian Ministry of Health, the Costing for Cervical Cancer Elimination in Nigeria by the World Health Organization,3 a Society-wide guideline for cervical cancer elimination,4 and a recent National Strategic Framework on vaccines for cancer control).5 These have accelerated the tempo and created new opportunities to achieve the country's vision for reducing the incidence and mortality of cancer in Nigeria. As a result, to support novel partnerships within and beyond traditional clinical services, including in community settings and non-health sector organizations, we propose the US-Nigerian Cancer Control Center for Research on Implementation Science and Equity (C3-RISE) Administration and Engagement Core (AEC). Our overarching goal is to improve cancer control in Nigeria and exert a sustained impact on public health in partnership with key stakeholders. Our proposed U54 Center brings together a transdisciplinary research team to meaningfully collaborate with key stakeholders, including individuals, communities, and local and state ministries of health. The U54 program will foster a Nigerian implementation science (IS) program to optimize the implementation of vaccines for cancer control efforts in Nigeria. The AEC will be responsible for the overall administration, coordination, and management of the Center and communication with the NIH. It will foster collaboration between researchers and key stakeholders and provide critical infrastructure for equitable implementation of evidence-based vaccines (i.e. human papillomavirus (HPV) vaccines for cervical cancer and hepatitis B (HepB) vaccines for liver cancer) for cancer control. We will also set a national and global standard for cutting-edge participatory IS research approaches9 in a resource-constrained setting that accelerates the adoption, adaptation, and sustainability of effective cancer control interventions in Nigeria. Our specific aims are: 1) To coordinate project management of the center wide-activities using agile methods; 2) To serve as a community engagement hub for IS in Nigeria using crowdsourcing methods; and 3) To evaluate Center's milestones and overall progress. By providing an infrastructure that facilitates Center-wide communications, operations, community outreach and evaluation, the AEC will serve as a central focal point to reinforce the overall vision of reducing the incidence and mortality of cancer while advancing the role of IS for equitable cancer control in Nigeria.

尼日利亚正处于癌症控制对策的十字路口。一方面，该国仍然是疫情的中心。 日益严重的癌症危机。另一方面，现有的指南（例如国家癌症控制中心 尼日利亚卫生部计划2，全球尼日利亚消除宫颈癌的成本估算 卫生组织，3 全社会消除宫颈癌指南，4 以及最近的国家战略 癌症控制疫苗框架）5。这些加快了步伐并创造了新的机遇 实现降低尼日利亚癌症发病率和死亡率的国家愿景。结果，为了 支持传统临床服务内外的新型伙伴关系，包括在社区环境和 非卫生部门组织，我们建议美国-尼日利亚癌症控制研究中心 实施科学与公平 (C3-RISE) 管理和参与核心 (AEC)。我们的首要任务 目标是与以下机构合作，改善尼日利亚的癌症控制并对公共卫生产生持续影响 关键利益相关者。我们提议的 U54 中​​心汇集了一个跨学科研究团队，以有意义地 与主要利益相关者合作，包括个人、社区以及地方和州卫生部。 U54 计划将促进尼日利亚实施科学 (IS) 计划，以优化实施 尼日利亚用于癌症控制工作的疫苗。 AEC 将负责整体管理， 中心的协调和管理以及与 NIH 的沟通。它将促进合作 研究人员和主要利益相关者之间的关系，并为公平实施提供关键基础设施 循证疫苗（即针对宫颈癌和乙型肝炎 (HepB) 的人乳头瘤病毒 (HPV) 疫苗） 肝癌疫苗）用于癌症控制。我们还将为尖端技术制定国家和全球标准 在资源有限的环境中参与式信息系统研究方法 9 可加速采用， 尼日利亚有效癌症控制干预措施的适应和可持续性。我们的具体目标是： 1) 使用敏捷方法协调中心范围内活动的项目管理； 2）作为社区服务 尼日利亚使用众包方法的伊斯兰国参与中心； 3) 评估中心的里程碑和 整体进展。通过提供促进中心范围内的通信、运营的基础设施， 社区外展和评估，AEC 将作为加强总体愿景的中心焦点 降低癌症的发病率和死亡率，同时提高信息系统在公平癌症控制方面的作用 尼日利亚。